Across TCGA pan-cancer cohorts, LINC01713 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01713’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01713 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01713 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

KIRC, KICH, and THCA are the cancer types where LINC01713 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01713 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.191	<.001	7	view →
KICH	All	All	−0.044	.015	5	view →
THCA	All	All	−0.035	.003	4	view →
PAAD	Male	All	+0.325	.040	2	view →
ESCA	All	II,III,IV	+0.170	.029	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC01713 RNA expression & survival · all LINC01713 data types